Finally, Jelic and colleagues3 have demonstrated that, in isolated circulating endothelial cells from OSA patients, both eNOS expression as well as phosphorylation at the activator residue was decreased in OSA patients compared with healthy subjects. This evidence concerns the gene NOS3 and obstructive sleep apnea syndrome.